Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33580363

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Immunol Immunother
Publication date
2021 Sep
First author
Boye K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Boye K
      type
      Author
    2. name
      Longhi A
      type
      Author
    3. name
      Guren T
      type
      Author
    4. name
      Lorenz S
      type
      Author
    5. name
      Næss S
      type
      Author
    6. name
      Pierini M
      type
      Author
    7. name
      Taksdal I
      type
      Author
    8. name
      Lobmaier I
      type
      Author
    9. name
      Cesari M
      type
      Author
    10. name
      Paioli A
      type
      Author
    11. name
      Løndalen AM
      type
      Author
    12. name
      Setola E
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Boye K
      type
      Author
    2. name
      Longhi A
      type
      Author
    3. name
      Guren T
      type
      Author
    4. name
      Lorenz S
      type
      Author
    5. name
      Næss S
      type
      Author
    6. name
      Pierini M
      type
      Author
    7. name
      Taksdal I
      type
      Author
    8. name
      Lobmaier I
      type
      Author
    9. name
      Cesari M
      type
      Author
    10. name
      Paioli A
      type
      Author
    11. name
      Løndalen AM
      type
      Author
    12. name
      Setola E
      type
      Author
    bibliography ids
    1. nci-bib-89f5b329603d862c9b632ac4
    book metadata
    content sha256
    6414cdf272513ff133fdfa8a6bbc97096423d4e1172630bb43db696e5490149a
    document type
    citation
    dois
    1. 10.1007/s00262-021-02876-w
    electronic publication date
    display
    2021 Feb 12
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33580363
    immutable id
    pubmed:33580363@6414cdf272513ff133fdfa8a6bbc97096423d4e1172630bb43db696e5490149a
    journal
    abbreviation
    Cancer Immunol Immunother
    issn electronic
    1432-0851
    issn print
    0340-7004
    issue
    9
    name
    Cancer immunology, immunotherapy : CII
    nlm unique id
    8605732
    pages
    2617-2624
    volume
    70
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33580363
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      1609699172562f316ae915a7cff78ae0675a3e5f2eb4b7354ea8af437ddd782b
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Sep
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33580363/
      title
      Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

      Preserved source evidence · Not medical advice